does semaglutide hurt kidneys Recent medical milestones include the 2025 FDA approval of Ozempic (semaglutide) specifically to slow the progression of chronic kidney disease (CKD) in patients with type 2 diabetes. Clinical trials Semaglutide for Chronic Kidney Disease:

Savojardo C, Manfredi M, Martelli PL, Casadio R

Integrate GLP-1 coverage with robust, wraparound support, such as condition management programs, nutrition counseling, and wellness coaching

A2: The primary concerns when considering co-administration of tirzepatide and topiramate include the potential for amplified gastrointestinal side effects (nausea, vomiting, diarrhea), increased risk of metabolic acidosis from topiramate, and potential exacerbation of cognitive side effects (brain fog)

Lower tolerance : Many patients report feeling intoxicated from smaller amounts than before treatment

The risk-benefit profile of semaglutide, especially in the context of renal health, appears favorable when compared with medications that have a more pronounced risk of nephrotoxicity

Represents 7.8% of revenue in 2025 at a CAGR of 15.3%